These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22452790)

  • 1. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.
    Dekker N; Meijer J; Koeter M; van den Brink W; van Beveren N; Kahn RS; Linszen DH; van Os J; Wiersma D; Bruggeman R; Cahn W; de Haan L; Krabbendam L; Myin-Germeys I;
    Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort.
    Stefanis NC; Dragovic M; Power BD; Jablensky A; Castle D; Morgan VA
    Schizophr Res; 2014 Jul; 156(2-3):211-6. PubMed ID: 24831390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
    Power BD; Dragovic M; Jablensky A; Stefanis NC
    Aust N Z J Psychiatry; 2013 Jan; 47(1):51-8. PubMed ID: 23042939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current cannabis use and age of psychosis onset: a gender-mediated relationship? Results from an 8-year FEP incidence study in Bologna.
    Allegri F; Belvederi Murri M; Paparelli A; Marcacci T; Braca M; Menchetti M; Michetti R; Berardi D; Tarricone I
    Psychiatry Res; 2013 Nov; 210(1):368-70. PubMed ID: 23919899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
    Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics influencing age at onset in psychotic disorders.
    Ongür D; Lin L; Cohen BM
    Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
    Manrique-Garcia E; Zammit S; Dalman C; Hemmingsson T; Andreasson S; Allebeck P
    Psychol Med; 2012 Jun; 42(6):1321-8. PubMed ID: 21999906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample.
    Ruiz-Veguilla M; Barrigón ML; Hernández L; Rubio JL; Gurpegui M; Sarramea F; Cervilla J; Gutiérrez B; James A; Ferrin M
    J Psychiatr Res; 2013 Aug; 47(8):1036-43. PubMed ID: 23684550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of gender on clinical and social characteristics of patients at psychosis onset: A report from the Psychosis Incident Cohort Outcome Study (PICOS).
    Bertani M; Lasalvia A; Bonetto C; Tosato S; Cristofalo D; Bissoli S; De Santi K; Mazzoncini R; Lazzarotto L; Santi M; Sale A; Scalabrin D; Abate M; Tansella M; Rugger M
    Psychol Med; 2012 Apr; 42(4):769-80. PubMed ID: 21995856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study.
    Donoghue K; Doody GA; Murray RM; Jones PB; Morgan C; Dazzan P; Hart J; Mazzoncini R; Maccabe JH
    Psychiatry Res; 2014 Mar; 215(3):528-32. PubMed ID: 24461684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.